Technology
Health
Medical

MEI Pharma

1,914

$1.61
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.17 (+11.81%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell MEI Pharma and other stocks, options, ETFs, and crypto commission-free!

About MEIP

MEI Pharma, Inc. engages in the clinical development of therapies for cancer. Its drug candidates includes Pracinostat, an oral HDAC inhibitor that is being developed in combination with azacitidine for the treatment of acute myeloid leukemia and myelodysplastic syndrome. Read More Its pipeline also consists of ME-401, an oral PI3K delta inhibitor; Voruciclib, an oral CDK inhibitor; and ME-344, a mitochondrial inhibitor. The company was founded on December 1, 2000 and is headquartered in San Diego, CA.

CEO
Daniel P. Gold
Employees
40
Headquarters
San Diego, California
Founded
2000
Market Cap
142.04M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.24M
High Today
$1.67
Low Today
$1.45
Open Price
$1.59
Volume
1.91M
52 Week High
$3.41
52 Week Low
$0.72

Collections

Technology
Health
Medical
Cancer Prevention
US
North America

MEIP Earnings

-$0.20
-$0.13
-$0.07
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
— per share
Actual
Expected May 7, After Hours

People Also Bought

Viking Therapeutics

50,946

$4.57

-3.59%

Viking Therapeutics

50,946

$4.57

-3.59%

Verastem

16,758

$2.58

+0.78%

Inovio

224,613

$7.59

-5.36%

Rigel Pharmaceuticals

10,157

$1.56

+1.96%

You May Also Like

FLSW
CFRX
FLAX
IEAWW
TWO
ANH-C
BABA
HFRO
ARNA
STG
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy MEIP

Market Price$1.61
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell MEI Pharma stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up